Adicet Bio, Inc. (ACET)

Adicet Bio Statistics

Total Valuation

Adicet Bio has a market cap or net worth of $110.67 million. The enterprise value is $17.33 million.

Market Cap	110.67M
Enterprise Value	17.33M

Important Dates

The last earnings date was Wednesday, November 5, 2025, after market close.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Adicet Bio has 161.70 million shares outstanding. The number of shares has increased by 20.75% in one year.

Current Share Class	153.26M
Shares Outstanding	161.70M
Shares Change (YoY)	+20.75%
Shares Change (QoQ)	+0.67%
Owned by Insiders (%)	0.81%
Owned by Institutions (%)	24.09%
Float	134.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.54
P/TBV Ratio	0.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.62, with a Debt / Equity ratio of 0.14.

Current Ratio	5.62
Quick Ratio	5.45
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9,305.46

Financial Efficiency

Return on equity (ROE) is -71.73% and return on invested capital (ROIC) is -42.67%.

Return on Equity (ROE)	-71.73%
Return on Assets (ROA)	-39.13%
Return on Invested Capital (ROIC)	-42.67%
Return on Capital Employed (ROCE)	-99.53%
Revenue Per Employee	n/a
Profits Per Employee	-$756,671
Employee Count	152
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.91% in the last 52 weeks. The beta is 1.61, so Adicet Bio's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	-45.91%
50-Day Moving Average	0.83
200-Day Moving Average	0.76
Relative Strength Index (RSI)	38.01
Average Volume (20 Days)	2,033,123

Short Selling Information

The latest short interest is 7.39 million, so 4.57% of the outstanding shares have been sold short.

Short Interest	7.39M
Short Previous Month	4.78M
Short % of Shares Out	4.57%
Short % of Float	5.49%
Short Ratio (days to cover)	3.48

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-120.97M
Pretax Income	-115.01M
Net Income	-115.01M
EBITDA	-114.44M
EBIT	-120.97M
Earnings Per Share (EPS)	-$1.25

Balance Sheet

The company has $103.10 million in cash and $15.54 million in debt, giving a net cash position of $87.56 million or $0.54 per share.

Cash & Cash Equivalents	103.10M
Total Debt	15.54M
Net Cash	87.56M
Net Cash Per Share	$0.54
Equity (Book Value)	109.14M
Book Value Per Share	1.19
Working Capital	87.55M

Cash Flow

In the last 12 months, operating cash flow was -$98.44 million and capital expenditures -$1.92 million, giving a free cash flow of -$100.36 million.

Operating Cash Flow	-98.44M
Capital Expenditures	-1.92M
Free Cash Flow	-100.36M
FCF Per Share	-$0.62

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Adicet Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.75%
Shareholder Yield	-20.75%
Earnings Yield	-109.65%
FCF Yield	-95.68%

Analyst Forecast

The average price target for Adicet Bio is $8.50, which is 1,141.96% higher than the current price. The consensus rating is "Buy".

Price Target	$8.50
Price Target Difference	1,141.96%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1